Lowest Price Guaranteed From USD 5,899
Published
April 2023
Pages
205
View Count
2502
Example Insights
 |
 |
 |
 |
 |
 |
 |
 |
Report Description
Polymers represent a versatile class of materials, as they are composed of multiple simple chemical units, commonly known as monomers. It is worth highlighting that polymers possess various favorable characteristics, such as high durability, resistance to chemicals, considerable strength, low cost and light-weight nature. As a result, polymers are used in various industries, including automotive, agriculture, construction, electronics, medical and textile. Specifically, in the medical domain, polymers play a crucial role in the development and manufacturing of drug formulations (to enhance the solubilization of poorly soluble drugs, improve stability or drug encapsulation to mask their unpleasant taste), drug delivery systems (to control the release of drug over time or target specific tissues) and medical devices (such as artificial joints, biosensors, dental implants, microfluidic devices (e.g. organ on a chip), orthopedic implants and stents). Pharmaceutical polymers / medical polymers have also played a significant role in the domain of tissue engineering, as they are useful in the creation of scaffolds that can be employed to repair damaged tissues. Further, medical-grade polymers are used in 3D bioprinting to develop hydrogels / bioinks for soft tissue generation, fabrication of temporary structures that will support tissue growth and coat the bioprinted tissues to improve their biocompatibility. Driven by the significant advancements in this domain and rising demand for novel medical therapies and devices, we believe that the pharmaceutical polymers / medical polymers market is likely to witness a steady growth over the coming years.
The Pharmaceutical Polymers / Medical Polymers Market - Distribution by Type of Polymer (Thermoplastic Polymers, Elastomers, Thermoset Polymers and Others), Area of Application (Medical Devices, Excipients, Packaging and Others) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future opportunity for pharmaceutical polymer / medical polymer manufacturers. Key inclusions of the report are briefly discussed below.
Recent Trends Related to Pharmaceutical Polymers / Medical Polymers
Technological advancements in the pharmaceutical polymer / medical polymer domain have led to the development of novel, functional polymers that are biodegradable in nature. It is worth mentioning that, after fulfilling their function, polymers are resorbed in the body. For instance, fibers of biodegradable polylactic acid and polyglycolic acid are commonly used as sutures to stitch wounds and surgical incisions. Further, smart polymers, with stimuli-responsive (pH, temperature and pressure), self-healing and shape memory behaviors are being explored. In recent years, polymers have also been modified to exhibit antibacterial properties, thereby, promoting their use in catheters and wound dressings (to prevent infections). Another key trend observed in the pharmaceutical polymers / medical polymers industry is recycling of polymer-based products in order to lower the production costs, optimize the usage of resources, reduce the waste generated and create a sustainable environment.
Challenges Associated with the Manufacturing of Pharmaceutical Polymers / Medical Polymers
The primary challenge associated with the manufacturing of pharmaceutical polymers / medical polymers is related to the maintenance of a controlled manufacturing environment in order to prevent contamination. Stringent regulatory guidelines are another challenge faced by pharmaceutical manufacturers as non-compliance with these regulations can lead to legal and financial consequences. Further, batch-to-batch variations amongst the final products can affect the product quality and performance; as a result, manufacturers need to ensure that their processes are reproducible and capable of producing consistent results.
Current Market Landscape of Pharmaceutical Polymer / Medical Polymer Manufacturers
The current landscape of pharmaceutical polymer / medical polymer manufacturers features a mix of close to 150 large, mid-sized and small companies, which have the required expertise to produce polymers for the pharmaceutical / medical industry. Majority of the players are focused on the manufacturing of amino-based polymers, followed by those having the capabilities to produce polysaccharide-based polymers. Further, medical-grade polymers are poised to play a significant role in shaping up the future market landscape, by enabling the development of new therapeutic modalities that were previously considered unattainable.
Market Size of Pharmaceutical Polymers / Medical Polymers Market
Driven by the indubitably rising need for economical, biodegradable and eco-friendly medical-grade polymers, the pharmaceutical polymers / medical polymers market is anticipated to witness steady growth in the foreseen future. Specifically, in terms of type of polymer, the market is anticipated to be primarily driven by thermoplastic polymers. Further, in the near future, close to 75% of the market is likely to be represented by players based in North America and Europe.
Key Players in the Pharmaceutical Polymers / Medical Polymers Market
Examples of key players (which have also been captured in this report) engaged in this domain include (arranged alphabetically) Americhem, Borealis, Celanese, Corel Pharma Chem, Eastman, Henkel, KRAIBURG TPE, Kuraray, Lubrizol Life Science, LyondellBasell, Phon Tech, SEQENS, Sumitomo Chemical, Solvay and Zylog ElastoComp.
Scope of the Report
The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments as defined in the below table:
| Key Report Attributes | Details | |
|
Forecast Period |
|
|
|
Type of Polymer |
|
|
|
Area of Application |
|
|
|
Key Geographical Regions |
|
|
|
Key Companies Profiled |
|
|
|
Customization Scope |
|
|
|
PowerPoint Presentation |
|
|
|
Excel Data Packs |
|
|
The study presents detailed information on current market landscape and future opportunity of various stakeholders engaged in this domain. Amongst other elements, the report includes:
One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. We have provided informed estimates on the likely evolution of the market in the mid to long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of polymer (thermoplastic polymers, elastomers, thermoset polymers and others), area of application (medical devices, excipients, packaging and others) and key geographical regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and rest of the world). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s evolution.
The opinions and insights presented in the report were influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following industry stakeholders:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Question 1: What are the uses of pharmaceutical polymers / medical polymers?
Answer: Pharmaceutical polymers / medical polymers are commonly used as binders, disintegrants, coatings, drug carriers, stabilizers, taste masking agents and release controlling agents.
Question 2: Which are most commonly used polymers in the pharmaceutical domain?
Answer: Some commonly used polymers in the pharmaceutical / medical sector include polyethylene, polyethylene glycol, polyglycolic acid, dextran and gelatin.
Question 3: How many players are engaged in manufacturing pharmaceutical polymers / medical polymers?
Answer: At present, close to 150 companies claim to manufacture different compositions of polymers, for a wide range of pharmaceutical / medical applications.
Question 4: What is the likely CAGR of pharmaceutical polymers / medical polymers market?
Answer: The global pharmaceutical polymers / medical polymers market is expected to grow at a CAGR of ~9% from 2023 to 2035. Specifically, in terms of type of polymer, majority share of the market is likely to be captured by thermoplastic polymers.
Question 5: Which region captures the largest share of the pharmaceutical polymers / medical polymers market?
Answer: At present, North America captures around 50% of the global pharmaceutical polymers / medical polymers. However, the pharmaceutical polymers / medical polymers market in Asia Pacific is anticipated to grow at a relatively faster pace (~10%), in the long term.
Question 6: Which segment is likely to have the largest share in the pharmaceutical polymers / medical polymers?
Answer: Currently, the medical devices segment dominates the pharmaceutical polymers / medical polymers market. However, the market is anticipated to be driven by polymers used as excipients in drug formulations, in the foreseen future.
Question 7: What are the partnership trends observed related to pharmaceutical polymers / medical polymers?
Answer: Product development agreements, acquisitions and distribution agreements are the most common types of partnerships inked by stakeholders in the pharmaceutical polymer / medical polymer domain.
Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Polymers
3.2.1 Historical Development of Polymers
3.2.2 Properties of Polymers
3.2.2.1 Physical Properties
3.2.2.1 Chemical Properties
3.2.2.2 Mechanical Properties
3.2.3 Classification of Polymers
3.2.3.1 Classification based on Molecular Forces
3.2.3.2 Classification based on Origin of Source
3.2.3.3 Classification based on Structure of Molecular Chain
3.2.3.4 Classification based on Monomers
3.2.3.5 Classification based on Backbone Chain
3.2.3.6 Classification based on Degradation Capability
3.2.3.7 Classification based on Morphology
3.2.4 Applications of Polymers in Pharmaceutical / Medical Domain
3.2.4.1 Pharmaceutical Formulation
3.2.4.2 Drug Delivery System
3.2.4.3 Gene Therapy
3.2.4.4 Stability Enhancer
3.2.4.5 Vaccine Adjuvant
3.2.4.6 Tissue Engineering
3.2.4.7 Dentistry
3.2.4.8 Packaging
3.2.4.9 Medical Device Coating
3.2.4.10 Others
3.3. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Polymer / Medical Polymer Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Source of Polymer
4.2.6. Analysis by Composition of Polymer
4.2.7. Analysis by Type of Polymer
4.2.8. Analysis by Area of Application
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis
5.4.1. Company Competitiveness Analysis: Players based in North America
5.4.2. Company Competitiveness Analysis: Players based in Europe
5.4.3. Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the World
6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Americhem
6.2.1. Company Overview
6.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Celanese
6.3.1. Company Overview
6.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Eastman
6.4.1. Company Overview
6.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Lubrizol Life Science
6.5.1. Company Overview
6.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. LyondellBasell
6.6.1. Company Overview
6.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.6.3. Recent Developments and Future Outlook
7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE
7.1. Chapter Overview
7.2. Borealis
7.2.1. Company Overview
7.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Henkel
7.3.1. Company Overview
7.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. KRAIBURG TPE
7.4.1. Company Overview
7.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. SEQENS
7.5.1. Company Overview
7.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Solvay
7.6.1. Company Overview
7.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD
8.1. Chapter Overview
8.2. Corel Pharma Chem
8.2.1. Company Overview
8.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Kuraray
8.3.1. Company Overview
8.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Phon Tech
8.4.1. Company Overview
8.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Sumitomo Chemical
8.5.1. Company Overview
8.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Zylog ElastoComp
8.6.1. Company Overview
8.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.6.3. Recent Developments and Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Composition of Polymer
9.3.5. Analysis by Type of Polymer
9.3.6. Analysis by Type of Partnership and Type of Polymer
9.3.7. Analysis by Area of Application
9.3.8. Analysis by Type of Partner
9.3.9. Most Active Players: Analysis by Number of Partnerships
9.3.10. Analysis by Geography
9.3.10.1. Intracontinental and Intercontinental Deals
9.3.10.2. International and Local Deals
10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Key Parameters
10.3.1. Demographical Factors
10.3.2. Environmental Factors
10.3.3. Legal Factors
10.3.4. Technological Factors
10.4. DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers
10.4.1. Arkema
10.4.2. Boron Molecular
10.4.3. Celanese
10.4.4. Chempilots
10.4.5. DSM
10.4.6. Evonik
10.4.7. Foryou Medical
10.4.8. JenKem Technology
10.4.9. Kraton
10.4.10. Kuraray
10.4.11. PolyVation
10.4.12. Polyzen
10.4.13. Zylog ElastoComp
10.5. Concluding Remarks
11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS
11.1 Chapter Overview
11.2 Recent Trends Related to Pharmaceutical / Medical Polymers
11.2.1 Development of Novel Pharmaceutical / Medical Polymers
11.2.1.1. Biodegradable Polymers
11.2.1.2. Smart Polymers
11.2.2. Recycling of Pharmaceutical / Medical Polymers
11.3. Concluding Remarks
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Pharmaceutical Polymers / Medical Polymers Market, 2023-2035
12.3.1. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Type of Polymer, 2023 and 2035
12.3.1.1. Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035
12.3.1.2. Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035
12.3.1.3. Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035
12.3.1.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.2. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Area of Application, 2023 and 2035
12.3.2.1. Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035
12.3.2.2. Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035
12.3.2.3. Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035
12.3.2.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.3. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Geography, 2023 and 2035
12.3.3.1. Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035
12.3.3.2. Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Asia-Pacific, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Cassion Biotech
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Thomas A. Harlan, Chief Executive Officer and Paul L. Deangelis, Chief Scientist
14.3. Celares
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Michael Joachim Sefkow, Business Development Manager
14.4. Daikyo Seiko
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Risako Tanaka, Head of Marketing and Business Strategy
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1. Executive Summary: Overall Market Landscape
Figure 2.2. Executive Summary: Partnerships and Collaborations
Figure 2.3. Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Formation of Polymers
Figure 3.2 Historical Development of Polymers
Figure 3.3 Classification of Polymers
Figure 3.4 Applications of Polymers in Pharmaceutical Domain
Figure 4.1 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Year of Establishment
Figure 4.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size
Figure 4.3 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 4.6 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Source of Polymer
Figure 4.7 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Composition of Polymer
Figure 4.8 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Number of Compositions of Polymer
Figure 4.9 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Type of Polymer
Figure 4.10 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Area of Application
Figure 5.1 Company Competitiveness Analysis: Players based in North America
Figure 5.2 Company Competitiveness Analysis: Players based in Europe
Figure 5.3 Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the world
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2019-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Composition of Polymer
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Polymer
Figure 9.7 Partnerships and Collaborations: Distribution by Area of Application
Figure 9.8 Partnerships and Collaborations: Distribution by Type of Partner
Figure 9.9 Most Active Players: Distribution by Number of Partnerships
Figure 9.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.11 Partnerships and Collaborations: Local and International Agreements
Figure 10.1 DELT Analysis: Impact of Internal and External Factors
Figure 10.2 DELT Analysis: Key Parameters
Figure 10.3 DELT Analysis: Arkema
Figure 10.4 DELT Analysis: Boron Molecular
Figure 10.5 DELT Analysis: Celanese
Figure 10.6 DELT Analysis: Chempilots
Figure 10.7 DELT Analysis: DSM
Figure 10.8 DELT Analysis: Evonik
Figure 10.9 DELT Analysis: Foryou Medical
Figure 10.10 DELT Analysis: JenKem Technology
Figure 10.11 DELT Analysis: Kraton
Figure 10.12 DELT Analysis: Kuraray
Figure 10.13 DELT Analysis: PolyVation
Figure 10.14 DELT Analysis: Polyzen
Figure 10.15 DELT Analysis: Zylog ElastoComp
Figure 10.16 DELT Analysis: Concluding Remarks
Figure 11.1 Types of Smart Polymers
Figure 12.1 Global Pharmaceutical Polymers / Medical Polymers Market, 2023-2035 (USD Billion)
Figure 12.2 Pharmaceutical Polymers / Medical Polymers Market, 2023 and 2035: Distribution by Type of Polymer
Figure 12.3 Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035 (USD Billion)
Figure 12.4 Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035 (USD Billion)
Figure 12.5 Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035 (USD Billion)
Figure 12.6 Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035 (USD Billion)
Figure 12.7 Pharmaceutical Polymers / Medical Polymers Market, 2023 and 2035: Distribution by Area of Application
Figure 12.8 Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035 (USD Billion)
Figure 12.9 Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035 (USD Billion)
Figure 12.10 Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035 (USD Billion)
Figure 12.11 Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035 (USD Billion)
Figure 12.12 Pharmaceutical Polymers / Medical Polymers Market, Distribution by Geography, 2023 and 2035
Figure 12.13 Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035 (USD Billion)
Figure 12.14 Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035 (USD Billion)
Figure 12.15 Pharmaceutical Polymers / Medical Polymers Market in Asia Pacific, 2023-2035 (USD Billion)
Figure 12.16 Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035 (USD Billion)
Figure 12.17 Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035 (USD Billion)
Figure 13.1 Concluding Remarks: Overall Market Landscape
Figure 13.2 Concluding Remarks: Company Competitiveness Analysis
Figure 13.3 Concluding Remarks: Partnership and Collaborations
Figure 13.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 4.1 Pharmaceutical Polymers / Medical Polymers: List of Manufacturers
Table 4.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Information on Type of Polymer, Method of Processing, Method of Sterilization and Area of Application
Table 4.3 Pharmaceutical Polymer / Medical Polymers Manufacturers: Information on Area of Application
Table 6.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in North America
Table 6.2 Americhem: Company Snapshot
Table 6.3 Americhem: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.4 Americhem: Recent Developments and Future Outlook
Table 6.5 Celanese: Company Snapshot
Table 6.6 Celanese: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.7 Celanese: Recent Developments and Future Outlook
Table 6.8 Eastman: Company Snapshot
Table 6.9 Eastman: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.10 Eastman: Recent Developments and Future Outlook
Table 6.11 Lubrizol Life Science: Company Snapshot
Table 6.12 Lubrizol Life Science: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.13 Lubrizol Life Science: Recent Developments and Future Outlook
Table 6.14 LyondellBasell: Company Snapshot
Table 6.15 LyondellBasell: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.16 LyondellBasell: Recent Developments and Future Outlook
Table 7.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in Europe
Table 7.2 Borealis: Company Snapshot
Table 7.3 Borealis: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.4 Borealis: Recent Developments and Future Outlook
Table 7.5 Henkel: Company Snapshot
Table 7.6 Henkel: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.7 Henkel: Recent Developments and Future Outlook
Table 7.8 KRAIBURG TPE: Company Snapshot
Table 7.9 KRAIBURG TPE: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.10 KRAIBURG TPE: Recent Developments and Future Outlook
Table 7.11 SEQENS: Company Snapshot
Table 7.12 SEQENS: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.13 SEQENS: Recent Developments and Future Outlook
Table 7.14 Solvay: Company Snapshot
Table 7.15 Solvay: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.16 Solvay: Recent Developments and Future Outlook
Table 8.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in Asia-Pacific
Table 8.2 Corel Pharma Chem: Company Snapshot
Table 8.3 Corel Pharma Chem: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.4 Kuraray: Company Snapshot
Table 8.5 Kuraray: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.6 Phon Tech: Company Snapshot
Table 8.7 Phon Tech: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.8 Sumitomo Chemical: Company Snapshot
Table 8.9 Sumitomo Chemical: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.10 Zylog ElastoComp: Company Snapshot
Table 8.11 Zylog ElastoComp: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 9.1 Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations, 2019-2022
Table 10.1 DELT Analysis: Impact of Internal and External Factors on Leading Players
Table 11.1 Pharmaceutical Polymers / Medical Polymers: List of Biodegradable Polymers
Table 14.1 Caisson Biotech: Company Snapshot
Table 14.2 Celares: Company Snapshot
Table 14.3 Daikyo Seiko: Company Snapshot
Table 15.1 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Year of Establishment
Table 15.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size
Table 15.3 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 15.4 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 15.5 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size and Location of Headquarters
Table 15.6 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Source of Polymer
Table 15.7 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Composition of Polymer
Table 15.8 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Number of Composition of Polymer
Table 15.9 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Type of Polymer
Table 15.10 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Area of Application
Table 15.11 Partnerships and Collaborations: Cumulative Year-wise Trend, 2019-2022
Table 15.12 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.13 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 15.14 Partnerships and Collaborations: Distribution by Composition of Polymer
Table 15.15 Partnerships and Collaborations: Distribution by Type of Polymer
Table 15.16 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Polymer
Table 15.17 Partnerships and Collaborations: Distribution by Area of Application
Table 15.18 Partnerships and Collaborations: Distribution by Type of Partner
Table 15.19 Most Active Players: Distribution by Number of Partnerships
Table 15.20 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.21 Partnerships and Collaborations: International and Local Agreements
Table 15.22 Global Pharmaceutical Polymers / Medical Polymers Market: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.23 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Type of Polymer, 2023-2035
Table 15.24 Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.25 Pharmaceutical Polymers / Medical Polymers Market for Elastomers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.26 Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.27 Pharmaceutical Polymers / Medical Polymers Market for Others: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.28 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Area of Application, 2023-2035
Table 15.29 Pharmaceutical Polymers / Medical Polymers Market for Medical Devices: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.30 Pharmaceutical Polymers / Medical Polymers Market for Excipients: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.31 Pharmaceutical Polymers / Medical Polymers Market for Packaging: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.32 Pharmaceutical Polymers / Medical Polymers Market for Others: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.33 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Geography, 2023-2035
Table 15.34 Pharmaceutical Polymers / Medical Polymers Market in North America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.35 Pharmaceutical Polymers / Medical Polymers Market in Europe: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.36 Pharmaceutical Polymers / Medical Polymers Market in Asia Pacific: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.37 Pharmaceutical Polymers / Medical Polymers Market in Latin America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.38 Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
The following companies / institutes / government bodies and organizations have been mentioned in this report.
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
YOU MAY ALSO LIKE
SUBSCRIBE TO INDUSTRY UPDATES